| 國立成功大學 |
2016-10 |
Risk of Recurrence After Surviving Severe Sepsis: A Matched Cohort Study
|
Shen, Hsiu-Nien;Lu, Chin-Li;Yang, Hsi-Hsing |
| 國立成功大學 |
2020 |
Risk of recurrent corneal erosion in patients with diabetes mellitus in Taiwan: a population-based cohort study
|
Jan, R.-L.;Tai, M.-C.;Ho, C.-H.;Chu, Chu C.-C.;Wang, J.-J.;Tseng, S.-H.;Chang, Y.-S. |
| 國家衛生研究院 |
2001-03 |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
Hung, CC;Hsieh, SM;Hsiao, CF;Chen, MY;Sheng, WH |
| 臺大學術典藏 |
2018-09-10T03:41:01Z |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
SZU-MIN HSIEH; CHIEN-CHING HUNG; Hung, C.-C. and Hsieh, S.-M. and Hsiao, C.-F. and Chen, M.-Y. and Sheng, W.-H. |
| 國立臺灣大學 |
2001 |
Risk of Recurrent Non-Typhoid Salmonella Bacteraemia after Early Discontinuation of Ciprofloxacin as Secondary Prophylaxis in Aids Patients in the Era of Highly Active Antiretroviral Therapy
|
洪健清; 謝思民; 盛望徽; HUNG, CHIEN-CHING; HSIEH, SZU-MIN; SHENG, WANG-HUEI |
| 臺大學術典藏 |
2020-09-30T03:23:24Z |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Chen M.-Y.; Hsiao C.-F.; Hsieh S.-M.; CHIEN-CHING HUNG; Chien-Ching Hung;Hsieh S.-M.;Hsiao C.-F.;Chen M.-Y.;Sheng W.-H. |
| 臺大學術典藏 |
2020-12-29T06:37:16Z |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Chen M.-Y.; Hsiao C.-F.; SZU-MIN HSIEH; Hung C.-C.; Hung C.-C.;Szu-Min Hsieh;Hsiao C.-F.;Chen M.-Y.;Sheng W.-H. |
| 臺大學術典藏 |
2021-02-26T02:00:27Z |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
Hung C.-C.;Hsieh S.-M.;Hsiao C.-F.;Chen M.-Y.;Wang-Huei Sheng; Hung C.-C.; Hsieh S.-M.; Hsiao C.-F.; Chen M.-Y.; WANG-HUEI SHENG |
| 臺大學術典藏 |
2021-12-01T02:30:34Z |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy
|
CHIEN-CHING HUNG; Hsieh S.-M.; Hsiao C.-F.; Chen M.-Y.; Sheng W.-H. |
| 國家衛生研究院 |
2007-09-01 |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance
|
Hung, CC; Hung, MN; Hsueh, PR; Chang, SY; Chen, MY; Hsieh, SM; Sheng, WH; Sun, HY; Huang, YT; Lo, YC; Hsiao, CF; Chang, SC |
| 國立臺灣大學 |
2007 |
Risk of Recurrent Nontyphoid Salmonella Bacteremia in Hiv-Infected Patients in the Era of Highly Active Antiretroviral Therapy and an Increasing Trend of Fluoroquinolone Resistance
|
洪健清; 洪敏南; 薛博仁; 張淑媛; 陳茂源; 謝思民; 盛望徽; 孫幸筠; 黃昱璁; 羅一鈞; 蕭金福; 張上淳; HUNG, CHIEN-CHING; HUNG, MIN-NAN; HSUEH, PO-REN; CHANG, SUI-YUAN; CHEN, MAO-YUAN; HSIEH, SZU-MIN; SHENG, WANG-HUEI; SUN, HSIN- YUN; HUANG, YU-TSUNG; LO, YI-CHUN; HSIAO, CHIN-FU; CHANG, SHAN-CHWEN |
| 臺大學術典藏 |
2018-09-10T06:12:35Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung, C.C. and Hung, M.N. and Hsueh, P.R. and Chang, S.Y. and Chen, M.Y. and Hsieh, S.M. and Sheng, W.H. and Sun, H.Y. and Huang, Y.T. and Lo, Y.C. and Hsiao, C.F. and Chang, S.C.; PO-REN HSUEH; SUI-YUAN CHANG; SZU-MIN HSIEH; WANG-HUEI SHENG; SHAN-CHWEN CHANG; HSIN-YUN SUN; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2007 |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.; Hung M.N.; PO-REN HSUEH; Chang S.Y.; Chen M.Y.; Hsieh S.M.; Sheng W.H.; Sun H.Y.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C.; Chang S.C.;Hsiao C.F.;Lo Y.C.;Huang Y.T.;Sun H.Y.;Sheng W.H.;Hsieh S.M.;Chen M.Y.;Chang S.Y.;PO-REN HSUEH;Hung M.N.;Hung C.C. |
| 臺大學術典藏 |
2020-06-18T08:26:20Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.;Hung M.N.;Hsueh P.R.;Sui-Yuan Chang;Chen M.Y.;Hsieh S.M.;Sheng W.H.;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Hung C.C.; Hung M.N.; Hsueh P.R.; SUI-YUAN CHANG; Chen M.Y.; Hsieh S.M.; Sheng W.H.; Sun H.Y.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2020-09-30T03:23:06Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Chang S.C.; Hsiao C.F.; Lo Y.C.; Huang Y.T.; Sun H.Y.; Sheng W.H.; Hsieh S.M.; Chen M.Y.; Chang S.Y.; Hsueh P.R.; Hung M.N.; Chien-Ching Hung;Hung M.N.;Hsueh P.R.;Chang S.Y.;Chen M.Y.;Hsieh S.M.;Sheng W.H.;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2007 |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.;Hung M.N.;Po-Ren Hsueh;Chang S.Y.;Chen M.Y.;Hsieh S.M.;Sheng W.H.;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Hung C.C.; Hung M.N.; PO-REN HSUEH; Chang S.Y.; Chen M.Y.; Hsieh S.M.; Sheng W.H.; Sun H.Y.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2020-12-29T05:33:16Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung M.N.; Hung C.C.; Hung C.C.;Hung M.N.;Hsueh P.R.;Chang S.Y.;Chen M.Y.;Hsieh S.M.;Sheng W.H.;Hsin-Yun Sun;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Hsueh P.R.; Chang S.Y.; Chen M.Y.; Hsieh S.M.; Sheng W.H.; HSIN-YUN SUN; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2020-12-29T06:37:22Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Sun H.Y.; Sheng W.H.; SZU-MIN HSIEH; Chang S.Y.; Chen M.Y.; Hsueh P.R.; Hung M.N.; Hung C.C.; Hung C.C.;Hung M.N.;Hsueh P.R.;Chang S.Y.;Chen M.Y.;Szu-Min Hsieh;Sheng W.H.;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2007 |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
SHAN-CHWEN CHANG; Hsiao C.F.; Lo Y.C.; Huang Y.T.; Sun H.Y.; Sheng W.H.; Hsieh S.M.; Chen M.Y.; Hsueh P.R.; Chang S.Y.; Hung M.N.; Hung C.C. |
| 臺大學術典藏 |
2021-02-26T02:00:19Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.;Hung M.N.;Hsueh P.R.;Chang S.Y.;Chen M.Y.;Hsieh S.M.;Wang-Huei Sheng;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Hung C.C.; Hung M.N.; Hsueh P.R.; Chang S.Y.; Chen M.Y.; Hsieh S.M.; WANG-HUEI SHENG; Sun H.Y.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2021-05-18T05:57:20Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.; Hung M.N.; Hsueh P.R.; Chang S.Y.; Chen M.Y.; Hsieh S.M.; Sheng W.H.; Sun H.Y.; YU-TSUNG HUANG; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2018-09-10T15:23:57Z |
Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy
|
Chou, Yu-Ju;Lin, Hui-Wen;Yang, Chia-Jui;Chen, Mao-Yuan;Sheng, Wang-Huei;Liu, Wen-Chun;Chang, Sui-Yuan;Hung, Chien-Ching;Hsueh, Po-Ren;Chang, Shan-Chwen; Chou, Y.-J. and Lin, H.-W. and Yang, C.-J. and Chen, M.-Y. and Sheng, W.-H. and Liu, W.-C. and Chang, S.-Y. and Hung, C.-C. and Hsueh, P.-R. and Chang, S.-C.; Chou, Yu-Ju;Lin, Hui-Wen;Yang, Chia-Jui;Chen, Mao-Yuan;Sheng, Wang-Huei;Liu, Wen-Chun;Chang, Sui-Yuan;Hung, Chien-Ching;Hsueh, Po-Ren;Chang, Shan-Chwen; 張上淳;陳茂源;薛博仁;盛望徽;洪健清;張淑媛; SUI-YUAN CHANG; Chou, Yu-Ju; Lin, Hui-Wen; PO-REN HSUEH; Yang, Chia-Jui; WANG-HUEI SHENG; SHAN-CHWEN CHANG; Chen, Mao-Yuan; CHIEN-CHING HUNG; Sheng, Wang-Huei; Liu, Wen-Chun; Chang, Sui-Yuan; Hung, Chien-Ching; Hsueh, Po-Ren; Chang, Shan-Chwen |
| 臺大學術典藏 |
2016 |
Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy
|
Chang S.-C.;PO-REN HSUEH;Hung C.-C.;Chang S.-Y.;Liu W.-C.;Sheng W.-H.;Chen M.-Y.;Yang C.-J.;Lin H.-W.;Chou Y.-J.; Chou Y.-J.; Lin H.-W.; Yang C.-J.; Chen M.-Y.; Sheng W.-H.; Liu W.-C.; Chang S.-Y.; Hung C.-C.; PO-REN HSUEH; Chang S.-C. |
| 臺大學術典藏 |
2020-12-18T08:37:20Z |
Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy
|
Chou Y.-J.; Lin H.-W.; Yang C.-J.; Chen M.-Y.; Sheng W.-H.; Liu W.-C.; Chang S.-Y.; Hung C.-C.; PO-REN HSUEH; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:30Z |
Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy
|
Chou Y.-J.; Lin H.-W.; Yang C.-J.; Chen M.-Y.; Sheng W.-H.; Liu W.-C.; Chang S.-Y.; CHIEN-CHING HUNG; Hsueh P.-R.; Chang S.-C. |
